{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:06:52Z","timestamp":1790251612518,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,23]],"date-time":"2010-11-23T00:00:00Z","timestamp":1290470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/2.0"},{"start":{"date-parts":[[2010,11,23]],"date-time":"2010-11-23T00:00:00Z","timestamp":1290470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Glucocorticoids (GCs) cause apoptosis and cell cycle arrest in lymphoid cells and constitute a central component in the therapy of lymphoid malignancies, most notably childhood acute lymphoblastic leukemia (ALL). PFKFB2 (6-phosphofructo-2-kinase\/fructose-2,6-biphosphatase-2), a kinase controlling glucose metabolism, was identified by us previously as a GC response gene in expression profiling analyses performed in children with ALL during initial systemic GC mono-therapy. Since deregulation of glucose metabolism has been implicated in apoptosis induction, this gene and its relatives, PFKFB1, 3, and 4, were further analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Gene expression analyses of isolated lymphoblasts were performed on Affymetrix HGU133 Plus 2.0 microarrays. GCRMA normalized microarray data were analyzed using R-Bioconductor packages version 2.5. Functional gene analyses of <jats:italic>PFKFB2-15A<\/jats:italic> and <jats:italic>-15B<\/jats:italic> isoforms were performed by conditional gene over-expression experiments in the GC-sensitive T-ALL model CCRF-CEM.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Expression analyses in additional ALL children, non-leukemic individuals and leukemic cell lines confirmed frequent <jats:italic>PFKFB2<\/jats:italic> induction by GC in most systems sensitive to GC-induced apoptosis, particularly T-ALL cells. The 3 other family members, in contrast, were either absent or only weakly expressed (<jats:italic>PFKFB1<\/jats:italic> and <jats:italic>4<\/jats:italic>) or not induced by GC (<jats:italic>PFKFB3<\/jats:italic>). Conditional PFKFB2 over-expression in the CCRF-CEM T-ALL <jats:italic>in vitro<\/jats:italic> model revealed that its 2 splice variants (PFKFB2-15A and PFKFB2-15B) had no detectable effect on cell survival. Moreover, neither PFKFB2 splice variant significantly affected sensitivity to, or kinetics of, GC-induced apoptosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our data suggest that, at least in the model system investigated, PFKFB2 is not an essential upstream regulator of the anti-leukemic effects of GC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-10-638","type":"journal-article","created":{"date-parts":[[2011,1,5]],"date-time":"2011-01-05T19:27:00Z","timestamp":1294255620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Expression, regulation and function of phosphofructo-kinase\/fructose-biphosphatases (PFKFBs) in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia cells"],"prefix":"10.1186","volume":"10","author":[{"given":"Michela","family":"Carlet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Janjetovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Rainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Panzer-Gr\u00fcmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Prelog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Meister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ploner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Kofler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,23]]},"reference":[{"issue":"Suppl 1","key":"2437_CR1","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/sj.cdd.4401456","volume":"11","author":"S Schmidt","year":"2004","unstructured":"Schmidt S, Rainer J, Ploner C, Presul E, Riml S, Kofler R: Glucocorticoid-induced apoptosis and glucocorticoid resistance: Molecular mechanisms and clinical relevance. Cell Death Differ. 2004, 11 (Suppl 1): S45-S55. 10.1038\/sj.cdd.4401456.","journal-title":"Cell Death Differ"},{"key":"2437_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/sj.cdd.4400969","volume":"9","author":"CW Distelhorst","year":"2002","unstructured":"Distelhorst CW: Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ. 2002, 9: 6-19. 10.1038\/sj.cdd.4400969.","journal-title":"Cell Death Differ"},{"key":"2437_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mce.2008.10.001","volume":"300","author":"KL Gross","year":"2009","unstructured":"Gross KL, Lu NZ, Cidlowski JA: Molecular mechanisms regulating glucocorticoid sensitivity and resistance. Mol Cell Endocrinol. 2009, 300: 7-16. 10.1016\/j.mce.2008.10.001.","journal-title":"Mol Cell Endocrinol"},{"key":"2437_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/sj.leu.2402733","volume":"17","author":"WJ Tissing","year":"2003","unstructured":"Tissing WJ, Meijerink JP, den Boer ML, Pieters R: Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia. Leukemia. 2003, 17: 17-25. 10.1038\/sj.leu.2402733.","journal-title":"Leukemia"},{"key":"2437_CR5","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1182\/blood-2005-07-2853","volume":"107","author":"S Schmidt","year":"2006","unstructured":"Schmidt S, Rainer J, Riml S, Ploner C, Jesacher S, Achm\u00fcller C, Presul E, Skvortsov S, Crazzolara R, Fiegl M, Raivio T, J\u00e4nne OA, Geley S, Meister B, Kofler R: Identification of glucocorticoid response genes in children with acute lymphoblastic leukemia. Blood. 2006, 107: 2061-2069. 10.1182\/blood-2005-07-2853.","journal-title":"Blood"},{"key":"2437_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1432-1327.1998.2540103.x","volume":"254","author":"D Heine-Suner","year":"1998","unstructured":"Heine-Suner D, Diaz-Guillen MA, Lange AJ, Rodriguez dC: Sequence and structure of the human 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase heart isoform gene (PFKFB2). Eur J Biochem. 1998, 254: 103-110. 10.1046\/j.1432-1327.1998.2540103.x.","journal-title":"Eur J Biochem"},{"key":"2437_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1042\/BJ20040752","volume":"381","author":"MH Rider","year":"2004","unstructured":"Rider MH, Bertrand L, Vertommen D, Michels PA, Rousseau GG, Hue L: 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. Biochem J. 2004, 381: 561-579. 10.1042\/BJ20040752.","journal-title":"Biochem J"},{"key":"2437_CR8","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/0006-291X(87)90364-0","volume":"143","author":"AD Colosia","year":"1987","unstructured":"Colosia AD, Lively M, El-Maghrabi MR, Pilkis SJ: Isolation of a cDNA clone for rat liver 6-phosphofructo 2-kinase\/fructose 2,6-bisphosphatase. Biochem Biophys Res Commun. 1987, 143: 1092-1098. 10.1016\/0006-291X(87)90364-0.","journal-title":"Biochem Biophys Res Commun"},{"key":"2437_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0968-0004(00)01699-6","volume":"26","author":"DA Okar","year":"2001","unstructured":"Okar DA, Manzano A, Navarro-Sabate A, Riera L, Bartrons R, Lange AJ: PFK-2\/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem Sci. 2001, 26: 30-35. 10.1016\/S0968-0004(00)01699-6.","journal-title":"Trends Biochem Sci"},{"key":"2437_CR10","doi-asserted-by":"crossref","first-page":"16796","DOI":"10.1016\/S0021-9258(18)37461-1","volume":"263","author":"K Kitamura","year":"1988","unstructured":"Kitamura K, Kangawa K, Matsuo H, Uyeda K: Phosphorylation of myocardial fructose-6-phosphate,2-kinase: fructose-2,6-bisphosphatase by cAMP-dependent protein kinase and protein kinase C. Activation by phosphorylation and amino acid sequences of the phosphorylation sites. J Biol Chem. 1988, 263: 16796-16801.","journal-title":"J Biol Chem"},{"key":"2437_CR11","doi-asserted-by":"publisher","first-page":"30927","DOI":"10.1074\/jbc.274.43.30927","volume":"274","author":"L Bertrand","year":"1999","unstructured":"Bertrand L, Alessi DR, Deprez J, Deak M, Viaene E, Rider MH, Hue L: Heart 6-phosphofructo-2-kinase activation by insulin results from Ser-466 and Ser-483 phosphorylation and requires 3-phosphoinositide-dependent kinase-1, but not protein kinase B. J Biol Chem. 1999, 274: 30927-30933. 10.1074\/jbc.274.43.30927.","journal-title":"J Biol Chem"},{"key":"2437_CR12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/ni0602-515","volume":"3","author":"DR Plas","year":"2002","unstructured":"Plas DR, Rathmell JC, Thompson CB: Homeostatic control of lymphocyte survival: potential origins and implications. Nat Immunol. 2002, 3: 515-521. 10.1038\/ni0602-515.","journal-title":"Nat Immunol"},{"key":"2437_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrc2817","volume":"10","author":"DA Tennant","year":"2010","unstructured":"Tennant DA, Duran RV, Gottlieb E: Targeting metabolic transformation for cancer therapy. Nat Rev Cancer. 2010, 10: 267-277. 10.1038\/nrc2817.","journal-title":"Nat Rev Cancer"},{"key":"2437_CR14","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1097-2765(00)00066-6","volume":"6","author":"JC Rathmell","year":"2000","unstructured":"Rathmell JC, Vander Heiden MG, Harris MH, Frauwirth KA, Thompson CB: In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Mol Cell. 2000, 6: 683-692. 10.1016\/S1097-2765(00)00066-6.","journal-title":"Mol Cell"},{"key":"2437_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.tibs.2004.09.008","volume":"29","author":"PS Hammerman","year":"2004","unstructured":"Hammerman PS, Fox CJ, Thompson CB: Beginnings of a signal-transduction pathway for bioenergetic control of cell survival. Trends Biochem Sci. 2004, 29: 586-592. 10.1016\/j.tibs.2004.09.008.","journal-title":"Trends Biochem Sci"},{"key":"2437_CR16","first-page":"482","volume":"204","author":"O Warburg","year":"1929","unstructured":"Warburg O: Ist die aerobe Glykolyse spezifisch f\u00fcr die Tumoren?. Biochem Z. 1929, 204: 482-487.","journal-title":"Biochem Z"},{"key":"2437_CR17","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB: Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009, 324: 1029-1033. 10.1126\/science.1160809.","journal-title":"Science"},{"key":"2437_CR18","first-page":"348","volume":"55","author":"EMC Strasser-Wozak","year":"1995","unstructured":"Strasser-Wozak EMC, Hattmannstorfer R, H\u00e1la M, Hartmann BL, Fiegl M, Geley S, Kofler R: Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line. Cancer Res. 1995, 55: 348-353.","journal-title":"Cancer Res"},{"key":"2437_CR19","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1096\/fj.06-6214fje","volume":"20","author":"S Schmidt","year":"2006","unstructured":"Schmidt S, Irving JA, Minto L, Matheson E, Nicholson L, Ploner A, Parson W, Kofler A, Amort M, Erdel M, Hall A, Kofler R: Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptor. FASEB J. 2006, 20: 2600-2602. 10.1096\/fj.06-6214fje.","journal-title":"FASEB J"},{"key":"2437_CR20","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1038\/sj.onc.1202820","volume":"18","author":"M L\u00f6ffler","year":"1999","unstructured":"L\u00f6ffler M, Tonko M, Hartmann BL, Bernhard D, Geley S, Helmberg A, Kofler R: c-myc does not prevent glucocorticoid-induced apoptosis of human leukemic lymphoblasts. Oncogene. 1999, 18: 4626-4631. 10.1038\/sj.onc.1202820.","journal-title":"Oncogene"},{"key":"2437_CR21","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1126\/science.7792603","volume":"268","author":"M Gossen","year":"1995","unstructured":"Gossen M, Freundlieb S, Bender G, M\u00fcller G, Hillen W, Bujard H: Transcriptional activation by tetracyclines in mammalian cells. Science. 1995, 268: 1766-1769. 10.1126\/science.7792603.","journal-title":"Science"},{"key":"2437_CR22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/j.1460-2075.1995.tb07021.x","volume":"14","author":"A Helmberg","year":"1995","unstructured":"Helmberg A, Auphan N, Caelles C, Karin M: Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J. 1995, 14: 452-460.","journal-title":"EMBO J"},{"key":"2437_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0165-4608(01)00655-0","volume":"135","author":"S Fears","year":"2002","unstructured":"Fears S, Chakrabarti SR, Nucifora G, Rowley JD: Differential expression of TCL1 during pre-B-cell acute lymphoblastic leukemia progression. Cancer Genet Cytogenet. 2002, 135: 110-119. 10.1016\/S0165-4608(01)00655-0.","journal-title":"Cancer Genet Cytogenet"},{"key":"2437_CR24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1096\/fj.04-3062fje","volume":"19","author":"W Parson","year":"2005","unstructured":"Parson W, Kirchebner R, M\u00fchlmann R, Renner K, Kofler A, Schmidt S, Kofler R: Cancer cell line identification by short tandem repeat profiling: power and limitations. FASEB J. 2005, 19: 434-436.","journal-title":"FASEB J"},{"key":"2437_CR25","volume-title":"Internet","author":"Z Wu","year":"2004","unstructured":"Wu Z, Irizarry RA, Gentleman RC, Martinez Murillo F, Spencer F: A model based background adjustment for oligonucleotide expression arrays. Internet. 2004, [http:\/\/www.bepress.com\/jhubiostat\/paper1\/]"},{"key":"2437_CR26","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J: Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5: R80-10.1186\/gb-2004-5-10-r80.","journal-title":"Genome Biol"},{"key":"2437_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","volume":"139","author":"I Nicoletti","year":"1991","unstructured":"Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991, 139: 271-279. 10.1016\/0022-1759(91)90198-O.","journal-title":"J Immunol Methods"},{"key":"2437_CR28","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1038\/sj.onc.1201399","volume":"15","author":"S Geley","year":"1997","unstructured":"Geley S, Hartmann BL, Hattmannstorfer R, L\u00f6ffler M, Ausserlechner MJ, Bernhard D, Sgonc R, Strasser-Wozak EMC, Ebner M, Auer B, Kofler R: P53-induced apoptosis in the human T-ALL cell line CCRF-CEM. Oncogene. 1997, 15: 2429-2437. 10.1038\/sj.onc.1201399.","journal-title":"Oncogene"},{"key":"2437_CR29","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/leu.2008.360","volume":"23","author":"G Gruber","year":"2009","unstructured":"Gruber G, Carlet M, Turtscher E, Meister B, Irving JA, Ploner C, Kofler R: Levels of glucocorticoid receptor and its ligand determine sensitivity and kinetics of glucocorticoid-induced leukemia apoptosis. Leukemia. 2009, 23: 820-823. 10.1038\/leu.2008.360.","journal-title":"Leukemia"},{"key":"2437_CR30","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/sj.leu.2405039","volume":"22","author":"C Ploner","year":"2008","unstructured":"Ploner C, Rainer J, Niederegger H, Eduardoff M, Villunger A, Geley S, Kofler R: The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia. Leukemia. 2008, 22: 370-377. 10.1038\/sj.leu.2405039.","journal-title":"Leukemia"},{"key":"2437_CR31","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.leukres.2009.06.029","volume":"34","author":"M Mansha","year":"2010","unstructured":"Mansha M, Carlet M, Ploner C, Gruber G, Wasim M, Wiegers GJ, Rainer J, Geley S, Kofler R: Functional analyses of Src-like adaptor (SLA), a glucocorticoid-regulated gene in acute lymphoblastic leukemia. Leuk Res. 2010, 34: 529-534. 10.1016\/j.leukres.2009.06.029.","journal-title":"Leuk Res"},{"key":"2437_CR32","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1182\/blood-2008-05-157842","volume":"113","author":"E Hulleman","year":"2009","unstructured":"Hulleman E, Kazemier KM, Holleman A, Vanderweele DJ, Rudin CM, Broekhuis MJ, Evans WE, Pieters R, den Boer ML: Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. Blood. 2009, 113: 2014-2021. 10.1182\/blood-2008-05-157842.","journal-title":"Blood"},{"key":"2437_CR33","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1038\/leu.2009.154","volume":"23","author":"K Eberhart","year":"2009","unstructured":"Eberhart K, Renner K, Ritter I, Kastenberger M, Singer K, Hellerbrand C, Kreutz M, Kofler R, Oefner PJ: Low doses of 2-deoxy-glucose sensitize acute lymphoblastic leukemia cells to glucocorticoid-induced apoptosis. Leukemia. 2009, 23: 2167-2170. 10.1038\/leu.2009.154.","journal-title":"Leukemia"},{"key":"2437_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1365-2249.1992.tb03084.x","volume":"88","author":"MA Nieto","year":"1992","unstructured":"Nieto MA, Gonz\u00e1lez A, Gamb\u00f3n F, D\u00edaz-Espada F, L\u00f3pez-Rivas A: Apoptosis in human thymocytes after treatment with glucocorticoids. Clin Exp Immunol. 1992, 88: 341-344. 10.1111\/j.1365-2249.1992.tb03084.x.","journal-title":"Clin Exp Immunol"},{"key":"2437_CR35","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1182\/blood.V86.11.4199.bloodjournal86114199","volume":"86","author":"M Brunetti","year":"1995","unstructured":"Brunetti M, Martelli N, Colasante A, Piantelli M, Musiani P, Aiello FB: Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. Blood. 1995, 86: 4199-4205.","journal-title":"Blood"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-638.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1471-2407-10-638\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-638","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-638.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T20:21:43Z","timestamp":1630614103000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-10-638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,23]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["2437"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-10-638","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,23]]},"assertion":[{"value":"8 July 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"638"}}